Valuation: Procter & Gamble Health Limited

Market Cap 83.54B 880M 786M 726M 658M 1.23B 1.25B 8.74B 3.46B 43.77B 3.3B 3.23B 138B P/E 2027 *
22.7x
P/E 2028 * 20.4x
Enterprise Value 83.54B 880M 786M 726M 658M 1.23B 1.25B 8.74B 3.46B 43.77B 3.3B 3.23B 138B EV / Sales 2027 *
5.4x
EV / Sales 2028 * 4.79x
Free-Float
47.81%
Yield 2027 *
2.16%
Yield 2028 * 2.35%
1 day-0.67%
1 week-3.33%
Current month-9.50%
1 month-7.51%
3 months-24.92%
6 months-3.26%
Current year-11.72%
1 week 4,728.3
Extreme 4728.3
5,205
1 month 4,728.3
Extreme 4728.3
5,875
Current year 4,699.7
Extreme 4699.7
6,955
1 year 4,699.7
Extreme 4699.7
6,955
3 years 4,640.3
Extreme 4640.3
6,955
5 years 3,883
Extreme 3883
6,955
10 years 736
Extreme 736
7,499.95
Manager TitleAgeSince
Chief Executive Officer 57 31/03/2018
Director of Finance/CFO - 30/09/2025
Chief Tech/Sci/R&D Officer - 31/08/2025
Director TitleAgeSince
Director/Board Member 57 31/03/2018
Director/Board Member 51 31/05/2019
Chairman 70 31/03/2025
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%-3.33%-17.58%+0.50% 880M
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average -0.67%+1.62%+31.46%+63.86% 400.52B
Weighted average by Cap. -0.26%+2.66%+40.98%+82.11%

Financials

2027 *2028 *
Net sales 15.47B 163M 146M 134M 122M 228M 232M 1.62B 641M 8.11B 612M 599M 25.56B 17.43B 184M 164M 152M 137M 257M 261M 1.82B 722M 9.13B 689M 675M 28.8B
Net income 3.67B 38.68M 34.54M 31.91M 28.91M 54.09M 54.99M 384M 152M 1.92B 145M 142M 6.06B 4.09B 43.05M 38.45M 35.52M 32.19M 60.22M 61.21M 427M 169M 2.14B 162M 158M 6.75B
Net Debt - -
Projected Income Statement - Annual - Procter & Gamble Health Limited
Logo Procter & Gamble Health Limited
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Employees
1,276
Date Price Change Volume
23/10/26 ₹5,032.75 -0.67% 963
22/10/26 ₹5,066.65 +0.34% 351
21/10/26 ₹5,049.65 -1.43% 244
19/10/26 ₹5,122.75 -1.60% 599
16/10/26 ₹5,205.85 +0.86% 660
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - Procter & Gamble Health Limited

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Procter & Gamble Health Limited
  1. Stock Market
  2. Stocks
  3. PGHL Stock